289 related articles for article (PubMed ID: 34299605)
41. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
42. Modulation of MicroRNAs by
Mahmoudian-Sani MR; Asadi-Samani M
Recent Pat Anticancer Drug Discov; 2020; 15(2):174-184. PubMed ID: 32603285
[TBL] [Abstract][Full Text] [Related]
43. Genome-wide miRNA response to anacardic acid in breast cancer cells.
Schultz DJ; Muluhngwi P; Alizadeh-Rad N; Green MA; Rouchka EC; Waigel SJ; Klinge CM
PLoS One; 2017; 12(9):e0184471. PubMed ID: 28886127
[TBL] [Abstract][Full Text] [Related]
44. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
Hanieh H
Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
[TBL] [Abstract][Full Text] [Related]
45. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
[TBL] [Abstract][Full Text] [Related]
46. miRNA-223 suppresses FOXO1 and functions as a potential tumor marker in breast cancer.
Wei YT; Guo DW; Hou XZ; Jiang DQ
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):113-118. PubMed ID: 28719355
[TBL] [Abstract][Full Text] [Related]
47. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.
Okuda H; Xing F; Pandey PR; Sharma S; Watabe M; Pai SK; Mo YY; Iiizumi-Gairani M; Hirota S; Liu Y; Wu K; Pochampally R; Watabe K
Cancer Res; 2013 Feb; 73(4):1434-44. PubMed ID: 23384942
[TBL] [Abstract][Full Text] [Related]
48. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells.
Guttilla IK; White BA
J Biol Chem; 2009 Aug; 284(35):23204-16. PubMed ID: 19574223
[TBL] [Abstract][Full Text] [Related]
49. Long non-coding RNA FEZF1-AS1 promotes breast cancer stemness and tumorigenesis via targeting miR-30a/Nanog axis.
Zhang Z; Sun L; Zhang Y; Lu G; Li Y; Wei Z
J Cell Physiol; 2018 Nov; 233(11):8630-8638. PubMed ID: 29797562
[TBL] [Abstract][Full Text] [Related]
50. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
51. miR-4443 Participates in the Malignancy of Breast Cancer.
Chen X; Zhong SL; Lu P; Wang DD; Zhou SY; Yang SJ; Shen HY; Zhang L; Zhang XH; Zhao JH; Tang JH
PLoS One; 2016; 11(8):e0160780. PubMed ID: 27504971
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention.
Munagala R; Aqil F; Vadhanam MV; Gupta RC
Cancer Lett; 2013 Oct; 339(2):175-84. PubMed ID: 23791885
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation.
Zuo J; Yu Y; Zhu M; Jing W; Yu M; Chai H; Liang C; Tu J
Cancer Biomark; 2018 Feb; 21(2):383-392. PubMed ID: 29103027
[TBL] [Abstract][Full Text] [Related]
54. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
Wang L; He M; Fu L; Jin Y
Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
[TBL] [Abstract][Full Text] [Related]
55. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
56. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
Chen Y; Wu N; Liu L; Dong H; Liu X
J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
58. FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation.
Cheng S; Huang Y; Lou C; He Y; Zhang Y; Zhang Q
Cancer Biol Ther; 2019; 20(3):328-337. PubMed ID: 30336071
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.
Browne G; Dragon JA; Hong D; Messier TL; Gordon JA; Farina NH; Boyd JR; VanOudenhove JJ; Perez AW; Zaidi SK; Stein JL; Stein GS; Lian JB
Tumour Biol; 2016 Jul; 37(7):8825-39. PubMed ID: 26749280
[TBL] [Abstract][Full Text] [Related]
60. MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2.
Wang LB; Feng L; He J; Liu B; Sun JG
Math Biosci Eng; 2019 Jul; 16(6):6923-6933. PubMed ID: 31698596
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]